SCHEMBL28519635

SCHEMBL28519635

Fc1ccc(C2CCCN2)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ KCNH2 Q12809 1/20 0.40
▸ PDCD1LG2 Q9BQ51 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.39
▸ OPRL1 P41146 4/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CHRM5 P08912 3/20 0.37
▸ CHRM3 P20309 3/20 0.37
▸ CHRM1 P11229 2/20 0.37
▸ CHRM2 P08172 2/20 0.37
▸ CHRM4 P08173 2/20 0.37
▸ NISCH Q9Y2I1 1/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CDK9 P50750 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25316221 1.00 MEN1 (0.44) MEN1KMT2AHTR2AHTR2CSLC6A4
SCHEMBL31444311 0.95 HTR2A (0.41) MEN1KMT2AHTR2AHTR2CSLC6A4
SCHEMBL31444461 0.94 HTR2A (0.40) MEN1KMT2AHTR2AHTR2CSLC6A4
SCHEMBL2239285 0.87 MEN1 (0.41) MEN1KMT2ASLC6A4KCNH2PDCD1LG2
SCHEMBL2239281 0.87 MEN1 (0.41) MEN1KMT2ASLC6A4KCNH2PDCD1LG2
Hydrochloric Acid SCHEMBL15017218 0.85 OPRL1 (0.40) MEN1KMT2AHTR2AHTR2CSLC6A4
Hydrochloric Acid SCHEMBL15017219 0.85 OPRL1 (0.40) MEN1KMT2AHTR2AHTR2CSLC6A4
SCHEMBL3333995 0.83 MEN1 (0.46) MEN1KMT2AHTR2AHTR2CHTR2B
SCHEMBL19599013 0.83 MEN1 (0.46) MEN1KMT2AHTR2AHTR2CHTR2B
SCHEMBL28840097 0.83 MEN1 (0.46) MEN1KMT2AHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 — — WO disclosed
CN-117683029-A Bcl-2 inhibitors 百济神州有限公司 2024-03-12 — — CN disclosed
CN-117430601-A Bcl-2 inhibitors 百济神州有限公司 2024-01-23 — — CN disclosed
CN-112437772-B Bcl-2 inhibitors 百济神州有限公司 2023-11-21 — — CN disclosed
CN-112437772-A Bcl-2 inhibitors 百济神州有限公司 2021-03-02 — — CN disclosed
Send feedback